Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Applied DNA Sciences | APDN | Oct 31, 2024 | 0.18 | -3.71 |
Applied Industrial Technologies | AIT | Oct 31, 2024 | 231.59 | -1.96 |
Applied Materials | AMAT | Oct 31, 2024 | 181.58 | -2.01 |
Applied Optoelectronics | AAOI | Oct 31, 2024 | 15.62 | -4.46 |
Applied Therapeutics | APLT | Oct 31, 2024 | 8.84 | -2.10 |
Applovin A | APP | Oct 31, 2024 | 169.39 | -1.32 |
AppTech Payments | APCX | Oct 31, 2024 | 0.66 | -7.59 |
Aprea Therapeutics | APRE | Oct 31, 2024 | 3.91 | -2.49 |
AptarGroup | ATR | Oct 31, 2024 | 167.91 | -0.66 |
Aptevo Therapeutics | APVO | Oct 31, 2024 | 0.27 | -3.50 |
Aptiv | APTV | Oct 31, 2024 | 56.83 | -17.72 |
Aptorum Group A | APM | Oct 31, 2024 | 1.43 | +2.14 |
Aptose Biosciences | APTO | Oct 31, 2024 | 0.38 | -2.38 |
APx Acquisition I A | APXI | Oct 31, 2024 | 11.81 | +0.01 |
APx Acquisition I Unit | APXIU | Oct 31, 2024 | 11.55 | 0.00 |
Apyx Medical | APYX | Oct 31, 2024 | 1.17 | -4.88 |
Aqua Metals | AQMS | Oct 31, 2024 | 0.15 | +2.03 |
AquaBounty Technologies | AQB | Oct 31, 2024 | 1.19 | 0.00 |
Aquaron Acquisition | AQU | Oct 31, 2024 | 11.00 | 0.00 |
Aquaron Acquisition Units | AQUNU | Oct 31, 2024 | 11.15 | 0.00 |
Aquestive Therapeutics | AQST | Oct 31, 2024 | 5.49 | -2.66 |
Aramark | ARMK | Oct 31, 2024 | 37.83 | -1.20 |
ARB IOT Group | ARBB | Oct 31, 2024 | 0.50 | +7.06 |
Arbe Robotics | ARBE | Oct 31, 2024 | 1.82 | -3.70 |
Arbor Realty Trust | ABR | Oct 31, 2024 | 14.74 | -2.19 |
Arbor Realty Trust D Pref | ABR-D | Oct 31, 2024 | 19.79 | -0.35 |
Arbor Realty Trust E Pref | ABR-E | Oct 31, 2024 | 19.55 | -0.46 |
Arbor Realty Trust F Pref | ABR-F | Oct 31, 2024 | 20.69 | +1.01 |
Arbutus Biopharma | ABUS | Oct 31, 2024 | 3.85 | -2.41 |
ARC Document Solutions | ARC | Oct 31, 2024 | 3.36 | -1.47 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.